Human rights, public health and medicinal cannabis use

Critical Public Health

Volumn 26, Issue 1, 2016, Pages 51-61

  Bone, Melissa ^a   Seddon, Toby ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

drug policy; human rights; medical cannabis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANNABIS USE; CONCEPTUAL FRAMEWORK; COST BENEFIT ANALYSIS; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; HUMAN RIGHTS; LIMB PAIN; MULTIPLE SCLEROSIS; NEOPLASM; PANCREAS CANCER; PATIENT CARE; PUBLIC HEALTH;

EID: 84947037524     PISSN: 09581596     EISSN: 14693682     Source Type: Journal    
DOI: 10.1080/09581596.2015.1038218     Document Type: Article

References (62)

1. J.Alder, (2006). The sublime and the beautiful: Incommensurability and human rights. Public Law, 4, 697–721.
2. M.Aldrich, (1997). History of therapeutic cannabis. In M.L.Mathre (Ed.), Cannabis in medical practice: A legal, historical, and pharmacological overview of the therapeutic use of marijuana (pp. 35–55). Jefferson, NC: McFarland.
3. G.Beck, (2008). Human rights adjudication under the ECHR: Between value pluralism and essential contestability. European Human Rights Law Review, 2, 214–244.
4. Bedrocan Canada. (2014). About Bedrocan. Retrieved December 13, 2013, from https://bedrocan.ca/about-us/
5. M.G.Blainey, (2015). Forbidden therapies: Santo Daime, Ayahuasca, and the prohibition of entheogens in western society. Journal of Religion & Health, 54, 287–302.
6. N.Boister, (2001). Penal aspects of the UN drug conventions. The Hague: Kluwer.
7. M.Bone, (2014). Is the medicinal consumption of cannabis effectively regulated from a human rights perspective? In M.Bone, P.Mungroo, & Y.Ping (Eds.), London cannabis conference (pp. 28–35). London: The House of Lords.
8. M.Bone,, P.Mungroo,, & Y.Ping, (2014). Cannabis regulation: The World is moving forward, what is stopping us? London Cannabis Conference. London: The House of Lords.
9. C.Boorse, (1975). On the distinction between disease and illness. Philosophy and Public Affairs, 5, 49–68.
10. A.Buchanan, (2008). Human rights and the legitimacy of the international order. Legal Theory, 14, 39–70.
11. Bud Buddies. (n.d.). Bud Buddies: Project Storm. Retrieved July 17, 2014, from http://projectstormthefilm.com/
12. R.Bunton,, & J.Coveney, (2011). Drugs’ pleasures. Critical Public Health, 21, 9–23.10.1080/09581596.2010.530644
13. Canadians for Safe Access. (n.d.). Cannabis research. Retrieved July 25, 2014, from http://safeaccess.ca/research/
14. W.Chapkis, (2007). Cannabis, consciousness, and healing. Contemporary Justice Review, 10, 443–460.10.1080/10282580701677550
15. J.Coggon, (2012). What makes health public? A critical evaluation of moral, legal, and political claims in public health. Cambridge: Cambridge University Press.
16. P.Conrad,, & K.K.Barker, (2010). The social construction of illness: Key insights and policy implications. Journal of Health and Social Behavior, 51(Suppl. 1), S67–S79.10.1177/0022146510383495
17. R.Coomber,, M.Oliver, & C.Morris, (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33, 325–356.10.1177/002204260303300204
18. J.Coveney,, & R.Bunton, (2003). In pursuit of the study of pleasure: Implications for health research and practice. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 7, 161–179.
19. V.Curran, (2014). Cannabis: How can drug science inform drug policy? In M.Bone, P.Mungroo, & Y.Ping (Eds.), London cannabis conference (pp. 36–41). London: The House of Lords.
20. M.Di Forti,, & R.M.Murray, (2014). An appropriate Legal and healthcare framework for cannabis use should take into account the effects of heavy use on mental health In M.Bone, P.Mungroo, & Y.Ping (Eds.), London cannabis conference (pp. 4–8). London: The House of Lords.
21. J.Donnelly, (2003). Universal human rights: In theory and practice (2nd ed.). New York, NY: Cornell University Press.
22. L.Edelstein, (1943). The hippocratic oath: Text, translation, and interpretation. Baltimore, MD: Johns Hopkins Press.
23. Foria. (2014). What is Foria? Retrieved August 25, 2014, from http://foriapleasure.com/pages/about-us
24. Global Drug Survey. (2014). The highway code: A Guide to safer more enjoyable drug use. Retrieved from http://www.globaldrugsurvey.com/brand/the-highway-code/
25. M.Guzman, (2003). Cannabinoids: Potential anti-cancer agents. Nature Reviews, 3, 745–755.
26. GW Pharmaceuticals. (2014). Sativex. Retrieved July 26, 2014, from http://www.gwpharm.com/Sativex.aspx
27. M.Hayry, (2004). Prescribing cannabis: Freedom, autonomy, and values. Journal of Medical Ethics, 30, 333–336.10.1136/jme.2002.001347
28. A.Hazekamp,, & E.R.Heerdink, (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. European Journal of Clinical Pharmacology, 69, 1575–1580.10.1007/s00228-013-1503-y
29. M.Holt,, & C.Treloar, (2008). Pleasure and drugs. International Journal of Drug Policy, 19, 349–352.10.1016/j.drugpo.2007.12.007
30. C.Jones, (2006). Cannabis as an alternative medicine. Queens Health Sciences Journal, 8, 29–33.
31. R.Labonté, (2008). Global health in public policy: Finding the right frame? Critical Public Health, 18, 467–482.10.1080/09581590802443588
32. L.Leung, (2011). Cannabis and its derivatives: Review of medical use. The Journal of the American Board of Family Medicine, 24, 452–462.10.3122/jabfm.2011.04.100280
33. P.Lucas, (2008). Regulating compassion: An overview of Canada’s federal medical cannabis policy and practice. Harm Reduction Journal, 5(5), 1–13.
34. R.Mackenzie, (2011). The neuroethics of pleasure and addiction in public health strategies moving beyond harm reduction: Funding the creation of non-addictive drugs and taxonomies of pleasure. Neuroethics, 4, 103–117.10.1007/s12152-010-9074-4
35. J.Nickel, (2010). Human rights. The Stanford encyclopedia of philosophy. Retrieved July 28, 2014, from http://plato.stanford.edu/archives/spr2012/entries/rights-human/
36. D.Nutt, (2015). Illegal drugs laws: Clearing a 50-year-old obstacle to research. PLOS Biology, 13, e1002047.10.1371/journal.pbio.1002047
37. N.J.Nutt,, L.A.King,, & D.E.Nichols, (2013). Effects of schedule I DRUG laws on neuroscience research and treatment innovation. Nature Reviews/Neuroscience, 14, 577–585.
38. M.J.Perry, (1998). The Idea of human rights: Four inquiries. New York, NY: Oxford University Press.
39. P.Police Foundation, (2000). Drugs and the law: Report of the inquiry into the misuse of drugs act 1971. London: Police Foundation.
40. M.Powers,, & R.Faden, (2006). Social justice: The moral foundations of public health and health policy. Oxford: Oxford University Press.
41. K.Race, (2009). Pleasure consuming medicine. Durham: Duke University Press.10.1215/9780822390886
42. A.E.Reiman, (2008). Self efficacy, social support and service integration at medicinal cannabis facilities in the San Francisco Bay area of California. Health and Social Care in the Community, 16, 31–41.
43. Rolles & Murkin. (2013). How to regulate cannabis: A practical guide. London: Transform Drug Policy Foundation.
44. E.B.Russo, (2005). Cannabis in India: Ancient lore and modern medicine. In R.Mechoulam (Ed.), Cannabinoids as therapeutics (pp. 1–22). Basel: Birkhauser Verlag.
45. E.B.Russo, (2007). History of cannabis and its preparations in saga, science, and sobriquet. Chemistry and Biodiversity, 4, 1614–1648.10.1002/cbdv.v4:8
46. G.Scott, (2013, November 15). Any positive change The evolving declaration of the Chicago recovery alliance. Hit hot topics conference, Liverpool: FACT Liverpool. Retrieved August 24, 2014, from http://hithottopics.com/index.php/conference/archives/2013-hot-topics
47. A.Sen, (2004). Health achievement and equity: External and internal perspectives In S.Anand, F.Peter, & A.Sen (Eds.), Public health, ethics and equity (pp. 263–268). Oxford: Oxford University Press.
48. R.K.Siegel, (2005). Intoxication: The universal drive for mind-altering substances. Vermont: Park Street Press.
49. T.Szasz, (2003). Ceremonial chemistry: The ritual persecution of drugs, addicts, and pushers (Revised ed.). Syracuse, NY: Syracuse University Press.
50. S.Tsakyrakis, (2009). Proportionality: An assault on human rights? International Journal of Constitutional Law, 7, 468–493.10.1093/icon/mop011
51. K.Tupper, (2008). The globalization of ayahuasca: Harm reduction or benefit maximisation? International Journal of Drug Policy, 19, 297–303.10.1016/j.drugpo.2006.11.001
52. A.Waldstein, (2010). Menace or medicine – Anthropological perspectives on the self-administration of high potency cannabis in the UK. Drugs and Alcohol Today, 10, 37–43.10.5042/daat.2010.0469
53. WHO. (1948/1998). Preamble of the Constitution of the World Health Organisation as adopted by the International Health Conference (Official Records of the WHO, No. 2) 100.
54. WHO. (n.d.). Trade, foreign policy, diplomacy and health: Glossary of globalization, trade and health terms. Retrieved December 10, 2014, from http://www.who.int/trade/glossary/story076/en/
55. City of Garden Grove v. Superior Court of Orange County, 68 Cal. Rptr. 3d 656 Cal. Ct. App. (2007).
56. Conant v. Walters. (9th Cir 2002) 309 F.3d 629, cert denied Oct. 14, (2003).
57. Gonzales v. Raich (previously Ashcroft v. Raich), 545 U.S. 1 (2005).
58. Hitzig v. Canada, CanLII 30796 (ON C.A.) (2003).
59. R v. Altham, EWCA Crim 7 (2006).
60. R v. Parker, 188 DLR (4th) 385 (2000).
61. R v. Quayle; R v. Wales; R v. Taylor and another; R v. Kenny; Attorney General’s Reference (No2 of 2004) EWCA Crim 1415 (2005).
62. United States v. Oakland Cannabis Buyers' Cooperative, 532 U.S. 483 (2001).